IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=Qnjz0WlDxPc The Evidence-based Medicine […]
Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung over the course of hours. In the modern intensive care unit, these […]
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems. However, autopsy and other studies have […]
Most people hospitalised with COVID-19 have at least one symptom six months after falling ill, according to a follow-up study of people in Wuhan China. The cohort study […]
The European Medicines Agency (EMA) has confirmed that health authorities can extract six doses of vaccine from each vial of Comirnaty, a vaccine against COVID-19 manufactured by Pfizer/BioNTech. […]
Is there case for mass vitamin D supplementation to mitigate the effects of covid-19? There are now more than 40 studies demonstrating that having optimal blood levels of 25(OH)-vitamin D […]
A meta-analysis of 11 randomised clinical trials of ivermectin to treat covid-19 infection shows a resoundingly positive effect. In summary, ivermectin treatment is associated with: Faster viral clearance Shorter duration […]
A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already […]
We are hearing almost hourly warnings of how the NHS will soon be overwhelmed with Covid-19 cases. Yet we have within our grasp two long-established drugs with activity […]
When a virus enters the body, it is picked up by certain cells of the immune system. They transport the virus to the lymph nodes where they present […]
Researchers at Massachusetts Institute of Technology (MIT) have developed an artificial intelligence (AI) model that can distinguish between asymptomatic people with covid-19 and healthy individuals. One of the […]
Combination treatment of COVID-19 patients with the antiinflammatory, arthritis drug baricitinib plus the antiviral drug remdesivir was superior to remdesivir monotherapy for cutting recovery time and improving symptoms. […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
